Article

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19…

medRxiv · 2021 · Bruce K. Patterson, author Edgar B. Francisco, author Ram Yogendra, author Emily Long, author Amruta Pise, author Hallison Rodrigues, author Eric Hall, author Monica Herrara, author Purvi Parikh, author Jose Guevara-Coto, author Timothy J. Triche, author Paul Scott, author Saboor Hekmati, author Dennis Maglinte, author Xaiolan Chang, author Rodrigo A Mora-Rodríguez, author Javier Mora, author

Key facts

Title Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection
First author Bruce K. Patterson, author Edgar B. Francisco, author Ram Yogendra, author Emily Long, author Amruta Pise, author Hallison Rodrigues, author Eric Hall, author Monica Herrara, author Purvi Parikh, author Jose Guevara-Coto, author Timothy J. Triche, author Paul Scott, author Saboor Hekmati, author Dennis Maglinte, author Xaiolan Chang, author Rodrigo A Mora-Rodríguez, author Javier Mora, author
Journal medRxiv
Published Jul 26, 2021
DOI 10.1101/2021.06.25.449905
Devices mentioned K810863
Product codes mentioned JJH, MVU

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature